INTRODUCTION
Increasingly studies are highlighting the major extent to which defects of complex I, the NADH-ubiquinol reductase of the mitochondrial electron transport chain, contribute to human disease pathology. Genetic mutations of subunits in this complex are the leading cause of inherited mitochondrial diseases which include Leigh's syndrome, LHON and MELAS (reviewed in Ref (1)). In addition there is strong evidence that complex I inhibition, through accumulated damage caused by reactive oxygen and nitrogen species and by the binding of environmental toxins, has a role in the development of the more prevalent neurodegenerative disorders including Parkinson's disease (2-4), Alzheimer's disease (5), Huntington's disease (6) , ALS (7, 8) , Down's syndrome (5) , schizophrenia (9) and even the process of aging itself (10).
Complex I is a large multimeric enzyme complex with an approximate molecular weight of one million. The bovine form isolated from beef heart has been analyzed extensively. In total, 45 different putative subunits have been identified, with 7 encoded by the mitochondrial DNA (mtDNA) and the remainder of nuclear DNA origin (11) . Purification protocols described thus far to obtain the enzyme for detailed characterization require large amounts of mitochondria as starting material, often in gram quantities that are not easily obtained from human tissue sources. Given the importance of the enzyme in human diseases, protocols that permit isolation of complex I from small amounts of biopsy tissue and even cell culture material would have great diagnostic utility. Moreover, a rapid procedure is important if multiple samples are by guest on http://www.jbc.org/ Downloaded from 4 being analyzed, for example in screening for protein markers of the above diseases. We have recently described a procedure to obtain complex I at high purity from human heart tissue by the simple method of solubilizing mitochondria in detergent, and separating component complexes based on macro-molecular size by sucrose gradient fractionation (12) . The large size of complex I causes this enzyme to sediment in the densest fractions of a sucrose gradient and thus can be isolated in a convenient manner.
However, 2.5 mg of mitochondrial protein are typically required, which in turn requires collection of 0.1 to 1g of tissue depending on tissue type. More recently, we have described an expedient isolation protocol for both the ATP synthase and PDH complexes from small amounts of human tissue by immunocapture using monoclonal antibodies (mAbs) made against these respective antigens (13, 14) . Here we report the successful purification of complex I from human heart with mAbs made against the bovine form of the enzyme. We provide a proteomic analysis of the complex that identifies the polypeptide constituents, and describe gel based techniques which allow separation of subunits for analyses of stoichiometry and the state of post-translational modification. Then isoelectric focusing was performed in three stages of applied potential difference; 500 V for 1 hour, 1000 V for 1 hour and 8000 V for up to 10 hours, until 60,000 Vh were achieved. Focused strips were then soaked in SDS-PAGE buffer (50 mM Tris.HCl pH 8.8, 6M urea, 30 % glycerol, 2 % SDS, 0.01 % bromophenol blue, 100 mM DTT) for 15 min at room temperature. Strips were applied to 15 % acrylamide gels for SDS-PAGE.
Gels were stained with Coomassie Brilliant Blue (Sigma) or Sypro Ruby (Molecular Probes) gel stains. Silver staining was performed according to Schevchenko et al. (16) .
Sample preparation for analysis by mass spectrometry. Sypro Ruby and silver stained 2D gel spots were excised using a ProteomeWorks  Robotic Imager and Spot Cutter (BioRad) and processed for mass spectrometric analysis as described previously (17) . Silver 7 stained 2D samples were manually destained in 5 mM potassium ferricyanide and 1 mM sodium thiosulfate, while Sypro Ruby stained gel spots were destained in a ProGest  digestion robot (Genomic Solutions Inc.). Reduction, alkylation and digestion of both Sypro Ruby and silver stained 2D gel spots were performed using the ProGest.
Silver-stained 1D gel bands (destained as described above) and Coomassie-stained 1D gel bands were manually processed as described previously (13) . Half of the final volume of digests from silver and Sypro Ruby stained gels (5-8 µL) was further subjected to strong cation exchange ZipTip (Millipore) clean up and concentration.
Peptides were eluted directly onto the MALDI targets and spectra were automatically acquired on a Voyager DE-STR  as reported previously (17) . Peptide mass fingerprints from baseline-corrected, noise-filtered and de-isotoped peaks and then analyzed using the program Protein Prospector, MS-Fit (18) with and without the Intellical algorithm from Applied Biosystems as described previously (17) . Since many of the NADH dehydrogenase subunits are small, predicted peptide mass fingerprints often contained only a limited number of peptides to match to peaks in the MALDI spectra. In these instances we resorted to manual inspection of the MALDI data as outlined in our earlier study (13) .
Identification of proteins by LC-MS/MS.
The remaining portion of selected digests was subject to automated LC-MS/MS analysis using a MicroTech Ultimate LC system coupled to a Finnigan LCQ DECA ion trap mass spectrometer equipped with a Finnigan dynamic nanospray source as described previously (13) . Each chromatogram was subsequently 8 analyzed with the program SEQUEST (19) as described previously (13) .The requirement for a protein assignment was at least one peptide for a particular protein having an X corr of > 1.7 for a + 1 ion, X corr of > 2.0 for a +2 ion, and X corr of > 3.0 for a +3 ion. In all cases ∆ corr must be greater than 0.1.
cDNA Cloning. cDNAs were amplified from a human heart Quickclone library Other contaminants include ANT1, the complex II 70 kDa protein, the complex III core protein 2 and complex IV subunit 5a (see Fig. 2 ). There is recent evidence for to resolve more subunits of the biochemically purified bovine complex I by 2D electrophoresis than the current study by isolating more complex I allowing analysis after sub-fractionation and also after heavy loading of pH 3-10 and 6-11 isoelectric focusing gel strips.
In all, 27 subunits were fully resolved from each other or from impurities either as single bands in 1D or as one or more unique spots on 2D gels. These include all of the nuclear-encoded subunits in which mutations causing human complex I deficiencies have been identified to date. Also uniquely resolved are the two complex I polypeptides, NDUFA9 and NDUFS4 , that are known to undergo post-translational modification (11) . The pattern of spots seen in Fig. 2 has been reproduced more than 10 times with several different preparations of human heart. Interestingly the NDUFA9 protein and the NDUFB4 protein have isoelectric points significantly different from that calculated from published gene sequences (see Fig 2B) .
While the DNA sequences of almost all of the putative subunits of complex I have been described, this is the first analysis of the protein composition of the human enzyme.
Three proteins were found in our complex I preparations that, until this point, have not been studied in the context of human complex I. These subunits are the GRIM-19 protein, the human neuronal protein NP17.3 and a hitherto unnamed hypothetical protein (NP_783313). The homologous proteins B16.6, ESSS and B14.7, respectively, have all been found in bovine complex I (11, 21) . We have cloned and confirmed the sequence of the cDNAs encoding these proteins from a human heart library (data not shown). Based on the nomenclature developed by Robinson and colleagues (22,23), the unnamed subunit has been termed NDUFA11, since its bovine counterpart was shown to be a part of the 1α subcomplex. Furthermore, it has been postulated that this protein
DISCUSSION
There is a critical need for efficient isolation procedures of intact complex I from human tissue and cell culture material for the molecular diagnosis of genetically derived and late onset neurodegenerative diseases that are associated with deficiencies of this component of the electron transport chain. Because of constraints on the amount of tissue that can be harvested from patients, a rapid protocol which works for small amounts of biopsy material, blood cells or cell cultured material is most desirable. In this report, we describe such a method that uses specific monoclonal antibodies to immunocapture complex I in amounts suitable for 1D and 2D electrophoresis followed by mass spectrometry for compositional analysis. We show that the human complex I purified by this immunocapture method contains the same polypeptides described in the studies of the bovine heart enzyme.
A total of 42 different component polypeptides were identified by mass spectrometry after electrophoresis (see Table I ). The ND6 protein was not identified in the current study but has been located in band 16 of the gel by a mAb specific for this polypeptide (see Fig. 1 ). This subunit has also has been detected in sucrose gradient purified complex I, when a larger amount of protein than used here was applied to the gel (25).
The smallest putative subunit, the NDUFC1 protein, was also detected at a position just below band 29 in this other investigation (25) . In contrast, ND3 was identified by a single cysteine-containing peptide in the current study but not in the other investigation where reduction and alkylation steps were omitted from gel processing procedures (25) .
The only subunit undetected by either study was ND4L, a hydrophobic mitochondrially encoded polypeptide with only a single large 23 residue trypsin fragment. Present in all preparations were the proteins GRIM-19 which has been linked to apoptosis, a 17.2 kDa protein homologous to a cell differentiation associated protein (DAP), a so-called neuronal protein NP17.3, and a previously uncharacterized complex I subunit NDUFA11. The bovine homologues of these proteins were recently reported in beef heart complex I as our work was in progress, and were termed B16.6, B17.2, ESSS and B14.7 respectively (11, 21, 26) .
It is difficult to establish whether any subunit is a bona fide subunit or an adventitiously associated impurity of a complex until the stoichiometry of that polypeptide has been determined and/or a key functional role has been identified. In the case of three of the polypeptides listed above, there are functions ascribed to each that are not related to complex I activity, and at least one, GRIM-19, has been found in both the nucleus and the cytosol (27) . Thus our finding that they are all present in the human complex I isolated by a different procedure than that used for the bovine enzyme is significant and supports the notion that they are constituents of complex I. Nevertheless, additional work is necessary to ascertain the function of these ancillary proteins.
In summary, we provide rapid purification of complex I from small amounts of human tissue which will be useful in studying mitochondrial diseases involving complex I, and 
